A European Medicines Agency committee now recommends withdrawing marketing authorization for Tavneos, an Amgen drug marketed in Europe by a CSL Limited subsidiary. Meanwhile, an FDA proposal to withdraw the drug from the U.S. market is set to go to a hearing. The post EMA: Amgen, Vifor Inflammatory Drug’s Benefits No Longer Outweigh Risks appeared…
The Medicare Cost Cap Act seeks to create a $5,000 cap on out-of-pocket costs for traditional Medicare beneficiaries. The post New Bill Led by Democrats Aims to Cap Medicare Out-of-Pocket Costs appeared first on MedCity News.
Rural health system Reid Health is using Abridge’s AI-powered documentation tech to reduce burnout among nurses. It appears to be working — after-shift charting is down by up to 45 minutes, and the RN vacancy rate has been cut more than in half, said Misti Foust-Cofield, Reid’s chief nursing officer. The post Documentation Tools Aren’t…
AI built on transparent, causal reasoning, systems that ground every output in validated biological mechanisms, show the pathway behind each recommendation, and cite their sources is what makes the difference between a tool that erodes clinical trust and one that rebuilds it. The post Why Generative AI Isn’t Enough: The Case for Causal Reasoning in…
It’s not low effort or underinvestment. It’s the steady-state output of an organization succeeding at the wrong thing. The post The Hidden Cost of “Good Enough” in Healthcare Experiences appeared first on MedCity News.
They are vast, deep, and nearly impossible to navigate without the right clinical lens applied on top. The real challenge facing health data platform companies and health system data teams is what to do with all of it. The post Have Healthcare Data Lakes Become “Data Swamps”? appeared first on MedCity News.
Counting hospital closures only tells part of the story, noted Duane Fitch, partner at Plante Moran. Across the country, hundreds of hospitals remain technically open while steadily shedding services their communities depend on, such as emergency care, obstetrics and psychiatric care. The post Why ‘Still Open’ Is the Wrong Way to Measure the Hospital Crisis…
Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This drug is a key piece of Ionis’s pivot away from partnering its assets, and instead developing and commercializing them on its own. The post A Metabolic Disease Posing Severe Pancreatic…
Upside’s $20 million raise was led by Aquiline and Flare Capital Partners, with support from existing investors including 645 Ventures, Freestyle Capital, Triple Impact Capital and Techstars. The post Upside Seeks to Solve the Housing Crisis Armed with $20M Raise appeared first on MedCity News.
UnitedHealthcare CEO Tim Noel, Optum CEO Dr. Patrick Conway, and other top executives and employees gave unprecedented access to journalists and others in order to show how the company is trying to reduce friction in healthcare. The goal was to change hearts and minds. Did the insurance behemoth succeed? The post UnitedHealthcare Threw Open Its…